Parkman Healthcare Partners’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,670,401
Closed -$4.53M 102
2024
Q1
$4.53M Buy
1,670,401
+1,066,781
+177% +$2.89M 0.56% 60
2023
Q4
$1.33M Buy
603,620
+103,620
+21% +$229K 0.19% 75
2023
Q3
$1.45M Buy
+500,000
New +$1.45M 0.27% 87
2020
Q2
Sell
-225,391
Closed -$572K 82
2020
Q1
$572K Sell
225,391
-174,609
-44% -$443K 0.27% 63
2019
Q4
$1.39M Buy
+400,000
New +$1.39M 0.4% 57